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ABSTRACT
Obstructive sleep apnea (OSA) affects about 15 million adults in the United States, and is
an independent risk factor for all-cause mortality. The under-diagnosing of OSA has been linked
to the inadequate screening by primary care practitioners (PCPs). Existing screening tools are not
widely used by PCPs possibly due to time constraints they experience as providers. This study
demonstrates how common high-risk diagnoses (obesity, hypertension, diabetes mellitus type 2,
dyslipidemia, arrhythmia, and coronary artery disease) can be used to help PCPs identify adult
patients at risk for OSA. Unlike other screening tools, these diagnoses are easy to identify in a
routine visit. This study was a retrospective chart review that used a random sample of 220
electronic health records. Seventy percent of the sample was positive for OSA, 69% had obesity,
and 33% had two or more high-risk diagnoses. The setting of this study was six sleep centers
located in five cities in Central Florida. Logistic regression was used to analyze the data to
determine interaction among variables and odds ratios. The variables “obesity” and “two or more
high-risk diagnoses” had significant effects on the likelihood of being diagnosed with OSA
independently of each other (odds ratio of 4.2 and 4.3 respectively; p<.001). However, there was
no significant interaction between these two variables (p=.56). The predictive value for an OSA
diagnosis using “obesity” was 83%, and it was 88% using “two or more high-risk diagnoses.”
These findings argue for the use of high-risk diagnoses to identify patients at risk for OSA. PCPs
are in an ideal position to increase the number of patients screened and treated for OSA because
they routinely see patients with these diagnoses in their practices. Proper diagnosis and treatment
of OSA has the potential to improve patients‟ outcomes and their quality of life.
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CHAPTER 1: INTRODUCTION
Obstructive sleep apnea (OSA) is a potentially disabling condition that if left untreated
can have life-threatening consequences. OSA is an independent risk factor for all-cause mortality
(Marshal et al., 2008). It negatively affects several health conditions and quality of life
(Devulapally, Pongonis, & Khayat, 2009; Somers et al., 2008). Despite the severe effects of
untreated OSA, it has a history of being under-diagnosed worldwide (Punjabi, 2008). Primary
care practitioners (PCPs) are in a key position to identify OSA high-risk patients. However, poor
screening in a primary health care (PHC) setting has been linked to the under-diagnosing of OSA
(S. A. Chung, Jairam, Hussain, & Shapiro, 2002; Dodson, 2008; P. Lavie, 2006; Merritt, 2004;
Reuveni et al., 2004; Skjodt, 2008). Patients usually present for routine consultation in a PHC
setting for common health issues, some of which might be related to OSA. A few screening tools
are available for evaluation of OSA high-risk, but they are not widely used in PHC settings
(Khassawneh et al., 2009; McNicholas, 2008). This may be due to PCPs‟ unfamiliarity with
these screening tools or due to time constraints. The purpose of this study is to demonstrate how
the different combinations of common diagnoses such as obesity, hypertension, diabetes mellitus
type 2, arrhythmia, and coronary artery disease can be used to help PCPs to identify OSA highrisk patients. Unlike some screening tools, these combinations of diagnoses are easy to identify
in a routine PHC visit and do not require extra assessment or documentation. PCPs may find it
useful to have a fast and simple way to determine, with a reasonable degree of certainty, which
patients to send for a polysomnogram, a test that is used to diagnose OSA. If a sensitive screen
could be developed that is based on combinations of diagnoses, PCPs could be able to diagnose
and treat more patients for OSA.
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Problem Background
Obstructive Sleep Apnea (OSA) is a disorder affecting an estimated 15 million adults in
the United States (F. Chung et al., 2008a; Somers et al., 2008). However, over 85% of people
with OSA are not diagnosed. OSA is characterized by repeated episodes of nocturnal apnea and
or hypopnea associated with hypoxemia. The repeated hypoxemia may produce sleep
fragmentation causing daytime excessive sleepiness, cognitive dysfunction, and reduced vitality
(Eckert & Malhotra, 2008; Gurubhagavatula, Nkwuo, Maislin, & Pack, 2008).

Obesity, Hypertension, and OSA
Obesity is the number one risk factor for OSA (Devulapally et al., 2009) and is associated
with a four-fold increase in prevalence of OSA (Somers et al., 2008). Coincidentally, 70% of
OSA patients are obese (Wolk, Shamsuzzaman, & Somers, 2003). According to the 2009 selfreported adult obesity survey, the prevalence of adult obesity in the United States was 26.7%
(Sherry, Blanck, Galuska, Pan, & Dietz, 2010). This prevalence was over 30% for the middleaged population alone. Overall, the incidence of obesity has more than doubled in the United
States over the last 30 years (Center for Disease Control and Prevention (CDC). Division of
Nutrition, Physical Activity and Obesity, National Center for Chronic Disease Prevention and
Health Promotion, 2010); therefore, more individuals are at risk for OSA.
The Joint National Committee guidelines identify OSA as one of the major causes of
secondary hypertension (US Department of Health and Human Services. National Institute of
Health. National Heart, Lung, and Blood Institute Committee, 2003). Hypertension and OSA are
common comorbidities with about 50% of individuals with OSA being hypertensive and about
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30% of hypertensive individuals having OSA (Devulapally et al., 2009; Somers et al., 2008).
Hence, individuals diagnosed with hypertension may also be at risk for OSA.

Health and Quality of Life
The proper treatment of OSA has been linked to improvement of several health
conditions and overall quality of life. The frequency with which these benefits are observed
varies with pre-existing conditions in the individual patient. Nevertheless, examples in the
literature of these benefits include the following: (1) decreased cardiovascular morbidity and
improved management of cardiac arrhythmia, arterial hypertension, and pulmonary hypertension
(Dodson, 2008; Kapur, Resnick, & Gottlieb, 2008; Merritt, 2004; Somers et al., 2008); (2)
decreased exacerbation of depressive symptoms (Cross et al., 2008; D. J. Schwartz & Karatinos,
2007); (3) decreased postoperative complications (F. Chung et al., 2008a; Lopez, Stefan,
Schulman, & Byers, 2008; Shafazand, 2009); (4) improved response in treatment of primary
headaches (Rains & Poceta, 2006); (5) decreased sickness-absence at work (Westerlund et al.,
2008); and (6) decreased motor vehicle accidents by reducing daytime sleepiness (S. A. Chung
et al., 2002; Dodson, 2008; Doghramji, 2008; Lopez et al., 2008; Pack, Platt, & Pien, 2008;
Reuveni et al., 2004).

Cost
The overall cost of OSA is similar to other chronic diseases (AlGhanim et al., 2008).
While the precise economic burden of OSA is difficult to measure, there is substantial evidence
demonstrating the significant costs associated with this condition. For example, several studies
have demonstrated the economic burden associated with untreated OSA, including health care
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cost and motor vehicle accidents (AlGhanim, Comondore, Fleetham, Marra, & Ayas, 2008;
Gurubhagavatula et al., 2008; Kapur, 2010; Sassani et al., 2004). Pagel (2008) did a controlled
analysis and found hospital stay reduction from 1.27 days/year before diagnosis of OSA to 0.54
days/year after one year of treatment. These results translate to 42% reduction in hospital
utilization after one year of treatment. With respect to road collisions, U.S. data from the year
2000 estimate costs directly related to OSA to be nearly $16 billion in this country alone (Pagel,
2008).

Purpose of Study
This study aims to investigate the effect of obesity in combination with other high-risk
diagnoses (hypertension, diabetes mellitus type 2, dyslipidemia, arrhythmias, and coronary artery
disease) in predicting the risk for diagnosis of OSA. The overwhelming number of patients with
undiagnosed OSA can be related to poor screening in the PHC setting (S. A. Chung et al., 2002;
Dodson, 2008; P. Lavie, 2006; Merritt, 2004; Reuveni et al., 2004; Skjodt, 2008). The use of
screening tools such as the Epworth Sleepiness Scale, STOP-BANG, and the Berlin
questionnaire are very helpful in proper identification of high-risk patients. However, many
PCPs may not be familiar with these screening tools or may not find the time to use them, thus
contributing to the under-diagnosis of OSA. The identification of high-risk diagnoses may be a
fast and simple way for PCPs to identify the patients at risk for OSA because they see patients
with these common diagnoses on a daily basis. Therefore, PCPs may feel more confident in
ordering a polysomnogram for diagnosis of OSA for those patients identified as having particular
combinations of high-risk diagnoses. Specifically, this study addresses the following research
question: What is the effect of obesity in combination with one as compared to two or more other
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high-risk diagnoses on the likelihood of being diagnosed with obstructive sleep apnea in a
primary health care setting?

Definitions
Obstructive Sleep Apnea
Obstructive Sleep Apnea (OSA) is a disorder characterized by repeated episodes of apnea
and or hypopnea associated with hypoxemia during sleep. It is related to a narrowing airway,
decreased tone of the pharyngeal dilator muscles, or increased compliance of upper airway
tissues (Somers et al., 2008). Apnea is considered a 10 second or greater pause in respiration due
to a collapse of the pharyngeal airway. Hypopnea is a decrease in respiration associated with a
fall in oxygen saturation by 4% from the patient‟s baseline. The number of apneas and
hypopneas per hour of sleep designate the apnea-hypopnea index (AHI) (Somers et al., 2008),
which is determined by a polysomnogram. The American Academy of Sleep Medicine, Task
Force (2009), developed clinical guideline for evaluation and management of OSA in adults. The
Task Force defined OSA as the presence of five or more AHI or respiratory disturbance index
(RDI) when the patient presents daytime sleepiness, fatigue, sleep disturbance, waking up
gasping for air, or loud snoring. Also, in the absence of symptoms, the diagnosis of OSA is
granted when AHI or RDI is equal or greater than 15 (Epstein et al., 2009). The severity levels of
OSA are related to the AHI or RDI score: 5-14 mild, 15-29 moderate, 30 or more severe
(American Academy of Sleep Medicine Task Force, 1999; Epstein et al., 2009; Young, Peppard,
& Gottlieb, 2002). Excessive daytime sleepiness is evident when it negatively affects the
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patient‟s daily activities. It is also demonstrated when the Epworth Sleepiness Scale score is
greater than 10 (Johns, 1991; Sassani et al., 2004; Talmage, Hudson, Hegmann, & Thiese, 2008).

Polysomnogram
Polysomnogram is an overnight procedure requiring the patient to spend a night in a sleep
center. Multichannel electrophysiological recordings of electroencephalogram, electroculogram,
electromyogram, and electrocardiogram are used to monitor sleep staging, nasal/oral air flow,
respiratory effort, oxygen saturation, snoring, heart rate, and leg movement. The equipment used
for the polysomnogram continuously records multiple physiological variables to detect
disturbance of breathing during sleep and determine the AHI (apnea-hypopnea index) (Dixon,
Schachter, & O'Brien, 2003; Somers et al., 2008). The scoring of these variables is performed by
a licensed polysomnographist, and a board certified sleep medicine professional should interpret
the study.

Continuous Positive Airway Pressure (CPAP)
CPAP is the most efficacious treatment for OSA. CPAP is a device that maintains
positive airway pressure according to pre-set values determined by the polysomnogram titration.
It acts as a pneumatic splint for the pharyngeal airway eliminating apneas, hypopneas, and
snoring during all stages of sleep (Bazzano, Khan, Reynolds, & He, 2007). It is applied via
nasal/face mask (with many choices of facial interface) and tubing connected to the CPAP
machine.
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High-risk Patients
The pathophysiology of OSA is complex and differs among individuals. In this study,
high-risk patients are those displaying a combination of obesity with any of the following
diagnoses: hypertension, diabetes mellitus type 2, dyslipidemia, arrhythmias, and coronary artery
disease; or non-obese patients displaying a combination of two or more of the above mentioned
diagnoses. There are other OSA high-risk characteristics, such as male gender, middle-age,
snoring, witnessed apnea or gasping, hypersomnolence, crowded pharyngeal airway (Mallampati
classification III or IV) (Jacobs & Coffey, 2009), enlarged neck size, morning headache, and
sexual dysfunction (Somers et al., 2008). Further risk factors include abuse of sedatives, alcohol,
and tobacco, as well as hereditary factors (Pagel, 2008). However, many of these factors are the
focus of current screening measures and the purpose of this study is to determine whether
something as simple as particular combinations of diagnoses can be used to identify individuals
at risk for OSA. Hence, assessment of these other high risk factors is not included in the present
study.

High-risk Diagnosis
For the purpose of this study the high-risk diagnoses are obesity, hypertension, diabetes
mellitus type 2, dyslipidemia, arrhythmias, and coronary artery disease. These diagnoses were
chosen due to their frequent incidence in a PHC setting and the frequent co-occurrences among
these diagnoses observed in the patients who were positive for OSA in the principal
investigator‟s (PI) PHC practice. Furthermore, the literature is prolific in linking these diagnoses
with OSA. For instance, untreated OSA contributes to persistent high blood pressure as it does
not allow the expected decrease in blood pressure at night (Devulapally et al., 2009; Endeshaw,
7

White, Kutner, Ouslander, & Bliwise, 2009; Golbin, Somers, & Caples, 2008); about 50% of
individuals with OSA are hypertensive (Devulapally et al., 2009; Somers et al., 2008). However,
there is a gap in the literature linking these different combinations of diagnoses with OSA.

Obesity
Obesity is documented as the most important cause of OSA (Hiestand, Britz, Goldman, &
Phillips, 2006; Somers et al., 2008). Individuals are considered obese when their body mass
index (BMI) is greater than or equal to 30 kg/m2. The BMI is a calculation of an individual‟s
weight and height, and it provides a reliable indicator of body fatness for most people. It does not
measure body fat directly, but research has shown that BMI correlates to direct measures of body
fat (Centers for Disease Control and Prevention, 2010). It is an inexpensive and easy-to-perform
method of screening for weight deviations. The BMI is calculated by dividing weight in
kilograms by the square of height in meters. Alternatively, BMI may be calculated by dividing
weight in pounds by the square of height in inches and multiplying by a conversion factor of 703
(CDC). For this study, obesity diagnosis will be defined as the documented BMI of 30 kg/m2 and
above.

Primary Health Care
A primary health care (PHC) practice is an office or clinic setting caring for patients with
acute and chronic illnesses. It also provides preventive care and health education for all ages and
genders (Nutbeam, 1998). Primary care practice, primary health care, general practice, family
practice, and internal medicine have many common functions, which are all classified under the
PHC category for this study.
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Primary Care Practitioner
Primary care practitioners (PCPs) are professionals practicing in primary health care.
They might be referred to as clinicians, healthcare practitioners, healthcare providers, primary
care providers, or family care practitioners. They are licensed professionals who deliver health
care in a systematic and professional way for common medical problems. They may be a
physician, a physician assistant, or a nurse practitioner (Vorvick & Zieve, 2009).

Screening Tools
Screening tools are instruments designed to help in the identification of a specific
disorder or multiple areas of concern. They do not intend to be conclusive for diagnostic
purpose, but rather indicate need of further assessment. The sensitivity of screening tools is the
probability they will identify the positive patients and their specificity is the probability they will
correctly identify the negative patient. Screening tools aid in the examination of usually
asymptomatic individuals to detect those with a high probability of having or developing a given
disease (Somers et al., 2008). Key OSA screening tools will be further described in chapter 2.

Assumptions
The reliability of the findings of this study depends on the following underlying
assumptions: (1) sleep centers where this study is conducted have a sample population
representative of the local community; (2) the technicians and clinicians in the sleep centers have
practice behaviors representative of standard care; and (3) the data are accurate in the health
records (as disclosed by the patient and/or referring clinician, and as entered by the sleep center
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technicians and/or clinicians). These assumptions are appropriate given the available data and
settings.

Implications for Practice
The proper screening of high-risk patients leading to diagnosis and treatment of OSA has
at least three implications for practice. First, proper screening has the potential to improve
patient outcomes ranging from improved health conditions to better quality of life when newly
diagnosed patients receive appropriate treatment (Somers et al., 2008). Second, more appropriate
treatment also has the benefit of health care savings. Third, PCPs‟ time may be saved for other
assessment and health teaching if study findings support the use of particular diagnoses for
detecting an increased risk for OSA. Results of this study could be combined with medical
information system programming to create an electronic warning message that appears when
particular combinations of diagnoses are present and there is no evidence of a polysomnogram
being ordered.
At the very least, knowledge gained from this study is expected to add to the present
literature and fill the gap regarding the importance of common combinations of diagnoses found
in a PHC setting to the risk of OSA. The results of this study will be disseminated in several
forms, such as professional publications, presentations at professional conventions, and local
seminars. It is anticipated that this study will present significant evidence-based data to impact
PCPs‟ practice in the proper screening for OSA.
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Summary
The need to find alternative ways for proper screening of OSA high-risk patients is
evident from the continuous under-diagnosing of OSA. PCPs are positioned in a key place to
improve the number of patients diagnosed and treated for OSA as they treat patients for other
common diagnoses that could be related to OSA. This study has the potential to demonstrate how
the different combinations of common diagnoses, such as obesity, hypertension, diabetes
mellitus type 2, dyslipidemia, arrhythmia, and coronary artery disease, can be used by PCPs to
predict patient‟s risk for OSA. One main value of these diagnoses combinations is how fast and
easy it is for PCPs to visualize them and identify OSA high-risk patients. Also, this information
could be used to create an electronic alert to cue PCPs to order a polysomnogram.
The next chapters present an in-depth development of this study. In chapter two, the
literature relevant to the research question is reviewed. There is prolific research on the topic of
OSA and its correlation with common diagnoses seen in a PHC, but there is a gap in the
literature that describes the use of combinations of these diagnoses as predictors for high risk
patients likely to be diagnosed with OSA. Next, chapter three presents the study design, methods,
and the data analysis method. Ethical considerations including security of protected health
information and limitations of the study are discussed as well. In chapter four, the findings are
presented objectively according to results of statistical analysis. Finally, chapter five focuses on a
discussion of the findings supporting the answer to the research question. Potential confounding
variables and the effect of study limitations on conclusions is discussed. Implications for practice
and recommendations for further studies will also be presented.
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CHAPTER 2: LITERATURE REVIEW
This chapter will provide a thorough discussion of the current literature regarding
obstructive sleep apnea (OSA). It is divided into six sections. First, an overview of what is
known about OSA with respect to pathophysiology and epidemiology is presented. Next, risk
factors for OSA are reviewed. In the third section, the cost associated with untreated OSA is
discussed. The following section presents the literature regarding the treatment of choice for
OSA. In the fifth section, the state of the science with respect to OSA screening is reviewed.
Finally, a case is made for using specific common diagnoses as an alternative to currently
available screening methods.

Obstructive Sleep Apnea
OSA is a condition featuring several episodes of apnea (complete airway obstruction) and
or hypopnea (partial airflow obstruction) despite inspiratory efforts. These events usually cause
arousals and sleep fragmentation. The recurrent events of airway obstruction often result in
oxygen desaturation and subsequent increase in arterial carbon dioxide (American Academy of
Sleep Medicine Task Force, 1999). The hypoxia severity may vary according to the number of
airway obstruction episodes. It may range from five to hundreds of events per hour (Khayat, Patt,
& Hayes, 2009). The diagnosis of OSA is confirmed when the polysomnogram shows apneahypopnea index (AHI) or respiratory disturbance index (RDI) of five or more and the patient
presents daytime sleepiness, fatigue, sleep disturbance, waking up gasping for air, or loud
snoring. Also, in the absence of symptoms, the diagnosis of OSA is granted when AHI or RDI is
equal or greater than 15 (Epstein et al., 2009). The severity levels of OSA are related to the AHI
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or RDI score: 5-14 mild, 15-29 moderate, 30 or more severe (American Academy of Sleep
Medicine Task Force, 1999; Epstein et al., 2009; Young et al., 2002).

Pathophysiology
The pathophysiology of OSA is multi-factorial and not well-understood. The potential
mechanism is related to reduced oxygenation caused by the repeated apneas and hypopneas
events. Therefore, surges of the sympathetic activation, including rises of catecholamine levels,
leads to endothelial dysfunction (Eckert & Malhotra, 2008). Moreover, there is evidence
showing increased inflammatory markers such as C-reactive protein in patients diagnosed with
OSA (Golbin et al., 2008; Khayat et al., 2009; Valham et al., 2008). The upper airway anatomy
in patients diagnosed with OSA is usually smaller and narrower then patients without this
condition. This presentation of the soft tissue structures surrounding the upper airway promotes
its collapse (Schwab et al., 1995). The Mallampati classification scores the visibility of the
tonsils, uvula, and soft palate. The visibility of these structures is scored from one (complete
visualization) through four (no visualization) (Jacobs & Coffey, 2009). The upper airway has
multiple purposes, including passage of air, food, and liquids. To accomplish these tasks
effectively, the muscle structures have collapsible properties allowing intermittent closure during
breathing, swallowing, and speech. Unfortunately, these mechanisms may fail during sleep and
collapse, blocking the air passage (Eckert & Malhotra, 2008). The recurrent blockage of air
during sleep decreases the oxygen saturation (hypoxemia) and increases the concentration of
carbon dioxide in the blood (hypercapnia) leading to sympathetic activation. These blockages
can be complete (apnea) or partial (hypopnea) and may cause arousal and sleep fragmentation
(Eckert & Malhotra, 2008).
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Epidemiology
An analysis of the Sleep in America 2005 Poll of the National Sleep Foundation showed
that about 25% of the adult population is at risk for OSA (Hiestand et al., 2006). OSA is the most
common of the sleep disorders (Calvin & Somers, 2009) with estimates of 2% to 7% of the adult
population worldwide (Punjabi, 2008). There is consensus that the prevalence of OSA in a PHC
setting is higher than in the general population (N. C. Netzer et al., 2003). This may be explained
by common diagnoses seen in PHC that are directly associated with OSA. For instance, studies
indicate that there is strong evidence linking OSA with cardiovascular diseases (Khayat et al.,
2009; N. C. Netzer, Stoohs, C. M. Netzer, Clark, & Strohl, 1999; Somers et al., 2008).
The Busselton Health Study demonstrated, after a 14-year follow-up, that moderate and
severe OSA is an independent risk factor for all-cause mortality associated with 33% mortality
versus 6.5% of healthy participants (Marshal et al., 2008). The Wisconsin Sleep Cohort found
significant mortality risk associated with untreated severe OSA in its 18-year follow-up study.
Severe OSA was an independent factor for all-cause mortality with three-fold greater risk
compared with the population without OSA (Young et al., 2008). Considering the high mortality
risk of severe OSA, treatment is recommended even for those patients without symptoms of
sleepiness (Pack et al., 2008). Patients identified as high-risk for OSA should be follow-upped
with a polysomnogram. Studies have shown that about 70% of high-risk individuals screened
with polysomnogram receive a diagnosis of OSA (Sassani et al., 2004).
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Risk Factors for OSA
Age and Gender
Age has been indicated as a risk factor for OSA, but there is no clear consensus among
several studies as to the age range at risk. Many studies present middle-age as high-risk, but the
definition of middle-age can vary considerably among authors, with the lower range varying
from 40 to 55 years. However, there is consensus that OSA incidence increases with age and
plateaus about age 65 (Eckert & Malhotra, 2008; Hiestand et al., 2006; Pavlova, Duffy, & Shea,
2008; Punjabi, 2008). The deterioration of the upper airway reflexes and anatomic changes due
to the aging process may place older people at high-risk for OSA (Eckert & Malhotra, 2008).
Middle-age and male gender have been associated with increased risk for OSA
(Gurubhagavatula et al., 2008; Pagel, 2008). In a 7-year follow-up study with middle-aged
healthy men, OSA was associated with increased risk to develop cardiovascular diseases in
almost five-fold. In the same study, when OSA was not treated the cardiovascular mortality risk
increased close to eleven-fold (Peker, Hedner, Norum, Kraiczi, & Carlson, 2002). In a study
comprising men with mean age 47 years, there was indication of cognitive dysfunction related to
OSA (Saunamäki, Himanen, Polo, & Jehkonen, 2009). It is not completely understood why OSA
prevalence is higher in males. The closest explanation is related to the fat deposition around the
pharyngeal airway which is more increased in males than in females (Eckert & Malhotra, 2008).
Males also have increased length of the pharyngeal airway which has been linked to airway
propensity to collapse.

15

Metabolic Syndrome
Metabolic syndrome is characterized by a combination of disorders, such as obesity,
diabetes mellitus type 2, dyslipidemia, and hypertension. Incidentally, these diseases have been
independently correlated with OSA. Obesity contributes to OSA not only by its anatomic effect,
but also by its dysfunctional metabolic activity (Cuhadaroğlu, Utkusavaş, Oztürk, Salman, &
Ece, 2009). In obese patients, OSA predicts the severity of insulin resistance due to the hypoxia
insult (Polotsky et al., 2009). Moreover, sleep deprivation is a common consequence of sleep
fragmentation due to OSA, which has been associated with metabolic syndrome and more
specifically to insulin resistance and high levels of glucose (Calvin & Somers, 2009).

Obesity
Obesity is defined as Body Mass Index (BMI) equal or over 30 kg/m2; overweight is
considered BMI equal or over 25 kg/m2. BMI is the calculation of an individual‟s weight and
height. The prevalence of obesity in the United States (US) has been steadily increasing at
alarming rates in the last few years; estimates are that more than half of the US population is
overweight (Center for Disease Control and Prevention (CDC). Division of Nutrition, Physical
Activity and Obesity, National Center for Chronic Disease Prevention and Health Promotion,
2010). It is well-documented in the literature that there is a direct relationship between obesity
and OSA (Dixon et al., 2003; Hiestand et al., 2006; Polotsky et al., 2009; A. R. Schwartz et al.,
2008; Tasali & Ip, 2008; Wolk et al., 2003). Obese patients present several features associated
with OSA; the most significant in predicting OSA severity was neck circumference equal or
greater than 43 cm (17 inches) for both men and women (Dixon et al., 2003). In a study with
patients presenting for bariatric surgery, the BMI was directly related to OSA incidence and
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severity. For patients with BMI between 40 and 50 kg/m2 the OSA incidence was close to 74%,
and those with BMI greater than 60 kg/m2 the OSA incidence increased to nearly 95% (Lopez et
al., 2008). Obesity is a significant risk factor in the progression of OSA (A. R. Schwartz et al.,
2008).

Diabetes Mellitus Type 2
Diabetes mellitus type 2 has been associated with OSA in several studies worldwide
(Aronsohn, Whitmore, Van Cauter, & Tasali, 2010; Botros et al., 2009; Lam et al., 2010; Tasali
& Ip, 2008). Sleep fragmentation and hypoxia are common occurrences in OSA which may
cause insulin resistance and adversely affect glucose metabolism (Polotsky et al., 2009; Tasali &
Ip, 2008). Patients with diabetes and untreated OSA have demonstrated poor glucose control
which is adversely affected by the OSA severity (Aronsohn et al., 2010). In a 5-year
observational cohort study with 544 participants, OSA was found to independently increase the
risk of developing diabetes. Furthermore, this study suggested that regular use of CPAP may
decrease the risk of diabetes in patients with severe OSA (Botros et al., 2009).

Dyslipidemia
Dyslipidemia has been linked to OSA in several cross-sectional studies (Drager, Jun, &
Polotsky, 2010; L. Lavie, 2008). Even though the independent association of the OSA effect on
dyslipidemia is still debatable, significant improvement on lipid profile has been reported on
OSA patients treat with CPAP (Cuhadaroğlu et al., 2009). The inflammatory and immune
response activated by the hypoxia experienced in OSA may cause endothelial cell dysfunction
promoting dyslipidemia (L. Lavie, 2008).
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Hypertension
The Seventh Report of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure (JNC 7) places OSA as significant cause of
secondary hypertension (US Department of Health and Human Services. National Institute of
Health. National Heart, Lung, and Blood Institute Committee, 2003). Hypertension has been
linked to OSA in several studies (Bazzano et al., 2007; Calvin & Somers, 2009; Devulapally et
al., 2009; Dodson, 2008; Endeshaw et al., 2009; Golbin et al., 2008; Khayat et al., 2009; Merritt,
2004; Peker et al., 2002; Somers et al., 2008; US Department of Health and Human Services.
National Institute of Health. National Heart, Lung, and Blood Institute Committee, 2003; Wolk
et al., 2003). The peripheral vasoconstriction caused by the repetitive hypoxia during respiratory
events interferes with the homeostasis balance affecting blood pressure control (Golbin et al.,
2008). Hypoxemia stimulates the release of catecholamine which involves vasoconstrictor
hormones such as norepinephrine, epinephrine, and dopamine (Eckert & Malhotra, 2008). The
intermittent state of nocturnal hypoxemia triggers the sympathetic system causing surges in the
blood pressure, which persist during the day in a carryover effect (Khayat et al., 2009).
Nocturnal blood pressure in normal individuals presents the dipping phenomenon where it
decreases 10-15% compared to their awake levels. However, OSA does not allow the expected
decrease in blood pressure at night and contributes to persistent high blood pressure during the
day as well (Devulapally et al., 2009; Endeshaw et al., 2009; Golbin et al., 2008). Kapur (2008)
and colleagues did a cross-sectional analysis including all subjects of the Sleep Heart Health
Study (1996), and they found stronger association of hypertension with OSA in individuals with
daytime sleepiness compared with individuals not reporting sleepiness. Additionally, OSA has
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been linked to aggravation of hypertension related to obesity due to common pathophysiological
mechanisms of OSA and obesity (Wolk et al., 2003).

Cardiovascular Diseases
Besides hypertension, many of the cardiovascular diseases have been linked to OSA. The
Sleep Heart Health Study had 6,046 participants in a multi-center cohort study. It was conducted
by the National Heart, Lung, and Blood Institute, and it demonstrated the relationship of
breathing sleep disorders with cardiovascular diseases among other implications (Sleep Heart
Health Study Research Group, 1996). Increasing evidence argues for an association between
OSA and cardiac arrhythmias, including atrial fibrillation, and bradyarrhytmias (Devulapally et
al., 2009; Golbin et al., 2008). In a 10-year study with patients diagnosed with coronary artery
disease, OSA was considered an independent risk factor for stroke events. Patients with mild and
severe OSA presented 2.4 and 3.6 times increased risk for strokes respectively (Valham et al.,
2008).

The Costs of Untreated OSA
Besides the significant direct health care costs associated with untreated OSA and the
aggravation of many diseases, other costs include motor vehicle accidents and lost productivity.
Daytime hypersomnolence is caused by sleep fragmentation which is one of the hallmarks of
OSA. The implications of daytime sleepiness for commercial drivers in particular are severe and
costly (Gurubhagavatula et al., 2008). In a controlled study with 1,443 truck drivers 13% were
found to be high-risk for OSA and 94.8% of those had a polysomnogram positive for OSA
(Talmage et al., 2008). Significant visual vigilance decline was found in drivers with untreated
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OSA (Tippin, Sparks, & Rizzo, 2009). Gurubhagavatula‟s study estimates cost of motor vehicle
accidents due to drivers with untreated OSA at 2.4 billion dollars per year. Another study by
Sassani (2004) estimates cost of OSA-related collisions, including fatalities, at 15.9 billion
dollars in the year 2000. Furthermore, the same study estimated that treating drivers for OSA
could have saved 980 lives involved in those crashes.
Work productivity has been estimated to be decreased in 37% due to sluggish thought
process and neurocognitive impairment of untreated employees with OSA (AlGhanim et al.,
2008; Gurubhagavatula et al., 2008). Decreased work performance may be related to daytime
hypersomnolence, irritability, reduced vitality, besides cognitive dysfunction (Pagel, 2008).
Screening high-risk employees, diagnosing, and treating them with CPAP has shown significant
economic benefit (AlGhanim et al., 2008).

Treatment for OSA
Continuous positive airway pressure (CPAP) is the treatment of choice for OSA
(Bazzano et al., 2007). When the diagnosis of OSA is confirmed with a polysomnogram, these
patients are referred for a second-night polysomnogram titration to assess appropriate pressure
settings for the CPAP. There are a few other treatment options for OSA, but discussing them all
is beyond the scope of this study. Patients properly treated with CPAP often have a total
resolution or significant improvement of respiratory events. Among other benefits, patients with
moderate to severe OSA have demonstrated improvement in the beta cell insulin secretory
capacity (Calvin & Somers, 2009) . Moreover, CPAP use for at least 4 hours per night promotes
significant control in glucose homeostasis (Calvin & Somers). Studies also have shown that
patients treated with CPAP have significant reduction in total cholesterol, low-density
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lipoprotein, and leptin levels (which has been linked to insulin sensitivity and resistance)
(Cuhadaroğlu et al., 2009).
Patients treated for OSA with CPAP have decreased C-reactive protein (CRP) levels
(Khayat et al., 2009). CRP is a significant risk factor for cardiovascular diseases (Khayat et al.,
2009) and it has been connected with OSA in several studies. Furthermore, the effect of CPAP in
reducing blood pressure levels has been demonstrated by several studies (Bazzano et al., 2007;
Devulapally et al., 2009). The most significant benefit of proper CPAP treatment on blood
pressure control was noted in patients with severe OSA and severe hypertension (Devulapally et
al., 2009).
CPAP treatment has demonstrated benefit in decreasing depression symptoms for patients
with concomitant diagnosis of OSA (D. J. Schwartz & Karatinos, 2007). There is a high
incidence of depression associated with OSA, and it has been suggested that it is due to the effect
of intermittent hypoxia on neural alterations (Cross et al., 2008). Moreover, OSA has been
known to act as a physiological trigger for headaches including migraine, cluster, tension-type,
and others as they may be precipitated by disturbance of the sleep pattern. Morning headaches in
particular have been associated with OSA which are resolved after effective treatment with
CPAP (Rains & Poceta, 2006).

Screening for OSA
Primary care practitioners (PCPs) play an important role in identifying patients at highrisk for OSA. They are in a key position to recognize comorbidities and physical features
associated with OSA (Pagel, 2008). They also have the opportunity to identify patients not
presenting with the classic symptoms but with enough evidence of comorbidities suggestive of
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high risk for OSA (S. A. Chung et al., 2002; Culpepper & Roth, 2009; Doghramji, 2008;
Khassawneh et al., 2009; P. Lavie, 2006). However, several studies have demonstrated that PCPs
recognize less than 15% of patients identified with OSA (N. C. Netzer et al., 1999; Reuveni et
al., 2004; Skjodt, 2008). For instance, the Berlin questionnaire was validated for use in primary
health care settings since 1996 (N. C. Netzer et al., 1999) but there is no significant evidence
showing its wide use by PCPs (McNicholas, 2008), hence the low percentage of patients
screened by PCPs over a decade later. In Jordan, a cross-sectional survey was conducted in five
PHC centers and the results showed that OSA symptoms were frequently present but often not
recognized (Khassawneh et al., 2009). PCPs using screening tools or with adequate training to
take an accurate sleep history have substantial improved identification of OSA high-risk patients
(Khassawneh et al., 2009; P. Lavie, 2006; N. C. Netzer et al., 1999; Skjodt, 2008).
Well-informed PCPs can give significant support for patients treated for OSA. They can
ensure patients receive adequate information and follow-up when treated with CPAP. PCPs
provide significant support by checking patients for persistence, improvement or resolution of
symptoms such as snoring and daytime somnolence after using CPAP (Doghramji, 2008).
Initially, and after the adjustment phase, PCPs continue to be an integral part of the long-term
follow-up, checking for adherence to treatment, comfort in using the equipment, knowledge of
equipment maintenance, and reassessment of weight increase or decrease over their baseline
(Culpepper & Roth, 2009; P. Lavie, 2006; Merritt, 2004).
Screening tools have been developed to help PCPs to identify the high-risk patients for
OSA, but, no single tool used alone has sufficient sensitivity and specificity to diagnose OSA or
predict its severity (Jacobs & Coffey, 2009). Screening tools may function as a reminder to PCPs
to ask patients about their sleep histories and identify the patients at risk for OSA (Reuveni et al.,
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2004). Some methods utilize self-reported questionnaires where patients rate their own
sleepiness and risk factors.

Epworth Sleepiness Scale
The Epworth Sleepiness Scale (ESS) was created in 1991 and revised in 1997 by Dr.
Murray Johns who is an internal medicine physician with specialization in sleep medicine in
Australia. The ESS has been translated and used by experts in sleep medicine in many countries
around the world (Johns, 2009; Rosenthal & Dolan, 2008). ESS has been validated in many
languages including Spanish (Chica-Urzola, Escobar-Córdoba, & Eslava-Schmalbach, 2007;
Vidal et al., 2007), Chinese (Chiner, Arriero, Signes-Costa, Marco, & Fuentes, 1999), Japanese
(Takegami et al., 2009), and Portuguese (Bertolazi et al., 2009).
The ESS was created with the purpose of measuring excessive daytime sleepiness in
adults. It is a simple self-administered 8 item questionnaire of 8 specific common situations in
daily living. These questions were developed based on identified low stimulus activities
promoting sleepiness. Individuals are requested to rate on a scale 0-3 how likely they would be
to doze off or fall asleep in each situation described in the 8 questions. The scale ranges from: (0)
would never doze, (1) slightly chance of dozing, (2) moderate chance of dozing, (3) high chance
of dozing. The eight situations are: (I) sitting and reading, (II) watching television, (III) sitting,
inactive in a public place, (IV) as a passenger in a car for an hour without a break, (V) lying
down to rest in the afternoon when circumstances permit, (VI) sitting talking to someone, (VII)
sitting quietly after lunch without alcohol, and (VIII) in a car, while stopped for a few minutes in
the traffic. Out of the total possible score of 24 points, 10 or higher is considered abnormal
(Johns, 1991). The scoring is simple and may take just a few seconds.
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The ESS was tested for reliability and internal consistency in a study with 104 medical
students and 150 patients. It was retested after five months with no significant change for the
healthy students and with significant change for the patients treated for OSA. The paired ESS
scores were consistent and highly correlated (r=0.82) with the Cronbach‟s alpha (0.88) (Johns,
1992). Rosenthal (2008) discussed the low sensitivity (66%) of the ESS in identifying OSA at
score of 10 and also the low specificity of only 48%. One limitation of the ESS is related to
patients reporting daytime sleepiness which may be due to other conditions including a fast-pace
life style (Rosenthal & Dolan, 2008). On the other hand, patients may under-report daytime
sleepiness. For instance, patients may gradually and chronically become hyper-somnolent during
the day and not realize it (Dodson, 2008).

Berlin Questionnaire
The Berlin Questionnaire was created at the Conference on Sleep in Primary Care in
April 1996 in Berlin, Germany. This conference had representation of 120 American and
German pulmonary and primary care physicians. The Berlin Questionnaire was developed based
on studies across the literature. They selected questions to elicit factors or behaviors that
consistently predicted the presence of sleep apnea (N. C. Netzer et al., 1999).
The questions on the Berlin Questionnaire focus on risk factors for sleep apnea. It
consists of one introductory question and four follow-up questions concern snoring; three
questions addressing daytime sleepiness, with a sub-question about sleepiness while driving. One
question concerns history of high blood pressure. Patients are also asked to provide information
on age, weight, height, gender, neck circumference, and ethnicity. The body mass index is
calculated from self-reported weight and height (N. C. Netzer et al., 1999).
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The predictive values for the Berlin Questionnaire vary among different populations. In a
primary care setting the sensitivity ranges from 54% to 86% and the specificity from 43% to
87%. The reliability according to the agreement and Cohen coefficient of test-retest was 96.3%.
However, the sensitivity and specificity were much lower (below 70%) and less predictive of
OSA in patients referred to sleep centers and in patients undergoing pulmonary rehabilitation (F.
Chung et al., 2008b).

STOP-BANG Questionnaire
Dr. Frances Chung and his team of seven researchers in Canada developed and validated
the STOP-BANG questionnaire in 2008 for OSA screening in the surgical setting. They were
looking for a concise and easy screening tool to use for pre-anesthesia evaluation of patients at
risk for OSA. By recognizing high-risk patients undiagnosed for OSA, it was expected that
perioperative morbidity and mortality would be decreased (F. Chung et al., 2008a; F. Chung et
al., 2008b; Lopez et al., 2008; Skjodt, 2008).
The four questions of the STOP questionnaire were based on the Berlin questionnaire
related to (S) snoring, (T) tiredness, (O) observed obstruction (stopped breathing), (P) pressure
(hypertension). The observed characteristics of individuals at high-risk for OSA from the STOP
questionnaire pilot study led to the addition of the BANG questions. (B) Body Mass Index (BMI)
greater than 35 kg/m2, (A) age over 50 years, (N) neck circumference greater than 40 cm (16
inches), and (G) male gender. The STOP-BANG questionnaire with three or more yes responses
suggests high risk for OSA (F. Chung et al., 2008a).
A pilot study was conducted with 592 preoperative adult patients. They answered the
STOP questionnaire and underwent an overnight polysomnogram regardless of the score. After
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the pilot study the same research process was conducted for 1,875 patients and the “BANG”
questions were added to the STOP questionnaire. The results from the polysomnogram were
analyzed considering the predictive parameters of the STOP-BANG questionnaire to evaluate its
validity. The polysomnogram with apnea-hypopnea index (AHI) over 5 was positive for the
diagnosis of OSA. The STOP-BANG questionnaire sensitivity at AHI above 5 (mild OSA) was
83.6% and the specificity was 56.4%; at AHI 15 and above (moderate OSA) the sensitivity was
92% and the specificity was 43%; at AHI 30 and above (severe OSA) the sensitivity was 100%
and the specificity was 37% (F. Chung et al., 2008a).

Summary
The literature is rich with evidence linking obstructive sleep apnea (OSA) to several
debilitating chronic diseases such as obesity, hypertension, diabetes mellitus type 2, and
cardiovascular diseases. However, research evaluating the use of combinations of these high-risk
diagnoses for identifying patients at risk for OSA was not found in the literature. Despite wellestablished evidence showing severe adverse effects for patients with untreated of OSA, this
disorder continues to be under-diagnosed. Proper screening and treatment for OSA has been
linked to improved patients‟ outcomes ranging from improved health conditions to better quality
of life. As documented in multiple studies, PCPs are in a key position to identify high-risk
patients for OSA, but frequently these patients are unrecognized. A few screening tools are
available for screening of patients at risk for OSA, but they are not widely used in the PHC
setting; time constraints often keep PCPs from focusing on OSA screening. It is evident that
there is a need to offer alternative ways for PCPs to properly screen patients at risk for OSA.
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This study has the potential to demonstrate how the different combinations of common
diagnoses such as obesity, hypertension, diabetes mellitus type 2, dyslipidemia, arrhythmia, and
coronary artery disease can be used by PCPs to predict a patient‟s risk for OSA. The use of
diagnoses combinations may be a fast and simple way for PCPs to identify the patients at risk for
OSA because they see patients with these common diagnoses on a daily basis. OSA screening
could be made even easier when using electronic health records. An electronic alert based on the
diagnoses combination algorithm could prompt PCPs to order a polysomnogram. This study may
lead PCPs to increase the screening of high-risk patients, and ultimately reduce the underdiagnosis of OSA.
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CHAPTER 3: STUDY OVERVIEW
The research question this study addressed was: What is the effect of obesity in
combination with one as compared to two or more other high-risk diagnoses on the likelihood of
being diagnosed with obstructive sleep apnea in a primary health care setting? Obstructive sleep
apnea (OSA) high-risk diagnoses in this study are defined as obesity, hypertension, diabetes
mellitus type 2, dyslipidemia, arrhythmias, and coronary artery disease. This chapter presents the
study methods, including setting and design and rationale for their appropriateness to answer the
research question; method for selecting study participants and data collection; protection of
human subjects and ethical considerations; and data analysis to evaluate study outcomes. The
limitations of this study are also presented, along with a discussion of implication for practice.

Setting
The setting of this study was six sleep centers located in five cities in Central Florida that
are under the administration of Florida Hospital Sleep Centers. They are certified by the
American Academy of Sleep Medicine or The Joint Commission. Most of these sleep centers
operate seven days a week and have a high volume of patients diagnosed with OSA. Hundreds of
different practitioners refer a variety of patients, resulting in an average of 3000
polysomnograms per year among the six centers. These patients are diverse in their ethnicity,
race, gender, and socioeconomic status. They represent a mix of health insurance coverage
including Medicare, Medicaid, private insurance, Health Maintenance Organization, and selfpay.
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Design
This study was a descriptive, cross-sectional study that used a two by two design (see
Table 1).

Table 1: Two by Two Design
Obesity: Yes
One non-obesity
high-risk diagnosis
Two or more non-obesity high-risk
diagnoses

Expect
high OSA
Expect highest OSA

Obesity: No
Expect
low OSA
Expect
high OSA

Sample
A random sample size of 220 electronic health records was selected from a pool of
available records. These patients completed a polysomnogram for assessment of OSA from
January 2009 to December 2010 in the previously mentioned sleep centers. The following were
the health record inclusion criteria: (a) polysomnogram ordered by PCPs (b) patient age 18 and
above. The exclusion criteria were: (a) polysomnogram done for titration, re-titration, or
reevaluation of previously diagnosed OSA; (b) polysomnogram done for evaluation of sleep
disorders other than OSA. The data necessary for this study were available via retrospective
chart review. Therefore no contact was made with patients.
The total sample had 49% (108) of males and 51% (112) of females. The age range was
from 18 to 82 years of age and the mean age was 48.9. The sample had a BMI range of 19 to 55
kg/m2 with a mean of 32.2 kg/m2. The total sample had 58% (127) of patients with obesity, 46%
(102) patients with hypertension, 20% (43) of patients with Diabetes Mellitus type 2, and 37%
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(81) of patients with dyslipidemia. Out of the patients diagnosed with OSA, 63% of them had
either moderate or severe OSA (see Table 2).

Table 2: Sample Demographics

Gender
Male
Female
Age
Mean
(Standard Deviation)
Median
(Range)
BMI
Mean
(Standard Deviation)
Median
(Range)
Diagnoses
Obesity
HTN
DM
Dyslipidemia
Arrhythmia
CAD
AHI/RDI
Mild (5 to 14.9)
Moderate (15 to 29.9)
Severe (30 and above)

Total Sample
(N=220)

OSA Positive
Sample Subgroup
(n=154)

49% (108)
51% (112)

61% (94)
39% (60)

48.9
(13.0)
49
(18-82)

50.7
(13.6)
51
(18-82)

32.2
(7.5)
30
(19-55)

33.6
(7.5)
32
(19-55)

58% (127)
46% (102)
20% (43)
37% (81)
6% (14)
7% (16)

69% (106)
56% (86)
27% (41)
45% (69)
6% (10)
9% (14)

-

37% (57)
29% (44)
34% (53)

The sample size (n=220) was sufficient for estimating a logistic regression model with
two independent variables plus the interaction term, making three predictors. There were no
missing data because only records that had full data available were used. Given that the
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incidence of OSA in the patient group for which health records were available was 70%, and
58% of the sample were obese, the power in the logistic regression for detecting an odds ratio of
2.0 or bigger was 80%, assuming significance level of p <0.05.

Procedure
The principal investigator (PI) applied for Institutional Review Board (IRB) approval
from the University of Central Florida first. Right after this approval was received, the PI applied
for Florida Hospital IRB approval which allowed access to the data at the sleep centers. The
review of health records was initiated immediately after the approval from both institutions‟ IRB
was received. The PI recorded data for the study variables using electronic data collection after
selecting health records that met the inclusion and exclusion criteria. The chart review was done
using electronic health records of the sleep centers. The study timeline was as follows: (a) data
collection February 2011; (b) data analysis February and March 2011; (c) summary of study
results and conclusion March 2011.

Study Variables
The demographic variables used to describe the sample were age and gender. The
dependent variable is a diagnosis of OSA which is a dichotomous variable. A value of (1) was
assigned for OSA positive and a value of (0) was assigned for OSA negative. OSA is considered
positive when the apnea-hypopnea index (AHI) or respiratory disturbance index (RDI) is equal
or greater than five. The variables composing the independent variables are obesity,
hypertension, diabetes mellitus type 2, dyslipidemia, arrhythmia, and coronary artery disease.
They were divided into obesity and non-obesity high-risk diagnoses. The body mass index (BMI)
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was collected and used to create the obesity variable. A value of (1) was assigned if the BMI was
greater than or equal to 30 kg/m2 and a value of (0) was assigned if the BMI was less than 30
kg/m2. The non-obesity high-risk diagnoses variables were created by assigning a value of (1) for
the presence of and a value of (0) for the absence of hypertension, diabetes mellitus type 2,
dyslipidemia, arrhythmias, or coronary artery disease.

Data Analysis
Descriptive statistics (mean, standard deviation, range, frequency, percentage) were used
to describe the sample (gender and age, and BMI) and summarize key study variables (obesity,
hypertension, diabetes mellitus type 2, dyslipidemia, arrhythmias, and coronary artery disease).
Logistic regression was used to address the research question. For this analysis, the dependent
and independent variables are nominal and they were coded as follows: dependent variable –
obstructive sleep apnea: yes (1), no (0); independent variables – obesity: yes (1), no (0) and nonobesity high-risk diagnosis 1 (0), non-obesity high-risk diagnosis 2+ (1). For analysis purposes
the interaction term was the result of obesity multiplied by non-obesity high-risk diagnoses
categories. Therefore, the logistic regression model contained the two main effect variables
(independent variables) and one interaction variable. The software system used for the data
analysis was SPSS 17.0.
If the interaction effect was significant, a post-hoc analysis would be conducted using 3
separate logistic regression analyses as follows: (1) obesity plus one high-risk diagnosis versus
obesity plus two or more high-risk diagnoses and non-obesity plus two or more high-risk
diagnosis; (2) obesity plus two or more high-risk diagnoses versus obesity plus one high-risk
diagnosis and non-obesity plus two or more high-risk diagnosis; (3) non-obesity plus two or
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more high-risk diagnosis versus obesity plus one high-risk diagnosis and obesity plus two or
more high-risk diagnoses. The odds ratios (ORs) would be evaluated for statistical significance
and then compared to determine which combination is most predictive of OSA.

Ethical Considerations
The method of retrospective chart review did not imply significant risks to patients. Their
health record numbers were disconnected from the data collected and there was minimal or no
risk of identification of patients‟ records. Data analysis only proceeded with a de-identified data
set. The data analysis and final report were at the group level preventing identification of any
individuals. Thus, no consent was obtained from patients.
A “study number” was assigned for each health record. The data collected for review was
stored in a secure database at Florida Hospital Neuroscience Clinical Research Institute. The file
containing the health record number and the study number was also kept by Florida Hospital as
per their IRB requirement for data integrity. This information is not available for outside access.
It will only be revealed on a need to know basis as required by law.
The PI has active privileges as a healthcare provider at Florida Hospital where this study
was conducted. The access to these records was granted by this organization‟s IRB preparatory
research approval as per HIPAA Reviews Preparatory to Research Form and finally by their
IRB. The data collection started after the official IRB approvals were received from University
of Central Florida and Florida Hospital.
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Study Limitations
The main limitation of this study may be related to the sample size. Data are not available
from past research to use in estimating the effect size. However, a clinically meaningful effect
size was used in estimating the desired sample size for analysis. Another consideration for
limitation is the sample from the Central Florida community only. It is possible that clinical
diagnoses could vary in different parts of the country with the “culture” of the healthcare
providers assigning them. However, this study is for exploratory purposes. Should significant
results be obtained, this study could be replicated in other parts of the United States.

Study Innovation
The overwhelming number of patients with undiagnosed obstructive sleep apnea (OSA)
can be related to poor screening in the PHC setting (N. C. Netzer et al., 1999; Reuveni et al.,
2004; Skjodt, 2008). The use of screening tools such as the Epworth Sleepiness Scale, STOPBANG, and the Berlin questionnaire are very helpful in proper identification of high-risk
patients. However, many PCPs may not be familiar with these tools or may not find the time to
use them, thus contributing to the underdiagnosis of OSA. For example, over 85% of people with
OSA are not diagnosed (F. Chung et al., 2008a; Somers et al., 2008).
This study investigates whether obesity in combination with other high-risk diagnoses
can be used to predict the risk of a positive diagnosis of OSA. Obesity and the other high-risk
diagnoses (hypertension, diabetes mellitus type 2, dyslipidemia, arrhythmias, and coronary artery
disease) are common diagnoses encountered in a PHC setting. Therefore, the use of these
diagnoses combinations to identify OSA high-risk patients may offer a simple way to prompt
PCPs to refer patients for a polysomnogram.
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There is a gap in the literature regarding combinations of diagnoses commonly seen in a
PHC setting as predictors for OSA high-risk. Findings from this study will contribute to the body
of knowledge and will warrant further research to generalize these results. Replication in other
populations would support the wide use of these diagnoses combination by PCPs. Also, this
would be beneficial in educating future PCPs to screen high-risk patients for OSA.
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CHAPTER 4: RESULTS OF STATISTICAL ANALYSIS
The results of the data analysis are presented objectively in this chapter and the
discussions of these findings are addressed in the next chapter. The results in Table 3 show the
percentage of obstructive sleep apnea (OSA) diagnosis for each variable in the sample without
consideration to interaction effects.

Table 3: OSA and the Sample Variables
Obesity: Yes

Obesity: No

One non-obesity high-risk diagnosis

18%

10%

Two or more non-obesity high-risk diagnoses

32%

10%

The total sample (n=220) had 70% (154) of patients positive for OSA. A third (33%, 72
patients) had two or more of the high-risk diagnoses whereas less than a third (27%, 59 patients)
had one of the high-risk diagnoses. Obesity was present in 58% (127) of patients in this sample.

Obesity with Two Plus High-Risk Diagnoses
Both obesity and having two or more high risk diagnoses were significant in the logistic
regression analysis (p < .001 and p = .02 respectively). However, the interaction term was not
significant (p = .60), indicating that the combination of obesity and two or more high risk
diagnoses does not improve prediction of those with OSA. Model statistics indicated a good fit
for the logistic regression: Hosmer & Lemeshow p = 1.0; -2LL=227.2; Model χ2 (3) 41.53, p <.
001. The overall classification rate was 73.6%.

36

The analysis was re-run to estimate odds ratios (ORs) without the interaction term in the
analysis. The OR for obesity was 4.2 (p <.001). The OR for two or more high-risk diagnoses was
4.3 (p <.001). Model statistics indicated a good fit for the logistic regression: Hosmer &
Lemeshow p = .87; -2LL= 227.5; Model χ2 (2) 41.25, p <. 001. There was no decrease in overall
classification rate when the interaction term was dropped.

Table 4: Sensitivity and Specificity
Sensitivity

Specificity

Predictive
Value of
Positive

Predictive
Value of
Negative

False
Positive
Rate

False
Negative
Rate

Obesity

69%

68%

83%

48%

32%

31%

Two or more
high-risk
diagnoses

44%

86%

88%

40%

14%

56%

Screening tests statistics based on the use of the two significant predictors (obesity and
two or more high-risk diagnoses) are depicted in Table 4. The sensitivity for obesity was higher
(69%) than for two or more high-risk diagnoses (44%). However, the specificity for two or more
high-risk diagnoses was higher (86%) than for obesity (68%).

Obesity with One High-Risk Diagnosis
Obesity in the logistic regression analysis was significant (p < .001). However, having
one high risk diagnosis was not significant (p = .47). The interaction term was not significant
(p = .57), indicating that the combination of obesity and one risk diagnosis does not improve
prediction of those with OSA. Model statistics indicated a good fit for the logistic regression:

37

Hosmer & Lemeshow p = 1.0; -2LL=242.2; Model χ2 (3) 26.60, p <. 001. The overall
classification rate was 70.5%.
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CHAPTER 5: DISCUSSION OF FINDINGS
This chapter presents a thorough discussion to answer the research question: What is the
effect of obesity in combination with one as compared to two or more other high-risk diagnoses
on the likelihood of being diagnosed with obstructive sleep apnea in a primary health care
setting? The findings presented in the previous chapter argue for the importance of using either
obesity or two or more of the high-risk diagnoses (hypertension, diabetes mellitus type 2,
arrhythmia, and coronary artery disease) independently to identify individuals at risk for
obstructive sleep apnea (OSA) in a primary health care (PHC) setting.
The answer to the research question is that the combination of obesity with high-risk
diagnoses (two or more, or just one) was not significant, as determined by the interaction
term. However, both obesity and two or more high-risk diagnoses had significant effects on the
likelihood of being diagnosed with OSA in a PHC setting. Patients with obesity or with two or
more of the high-risk diagnoses were found to have over four-fold likelihood of an OSA
diagnosis as seen in Table 5. The use of two or more high-risk diagnoses independently of
obesity as a predictor for OSA has not been previously described in the literature. However, in
this study it was found to be significant in the logistic regression analysis, thus arguing for the
use of two or more high-risk diagnoses for identifying patients at risk for OSA.

Table 5: Odds Ratio for OSA Diagnosis for Key Risk Factors
Odds Ratio
4.2
4.3

Obesity
Two or more high-risk diagnoses
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Effect of Study Limitations on Conclusions
Nevertheless, the study had four main limitations. First, the pool of health records
available included only the records with full documentation. Approximately 10% of the records
could not be included because the scanning of the medical history was missing. Second, some of
the records may have had diagnoses under estimated as their documentations were dependent on
accurate disclosure by the patient or primary care practitioner (PCP). Third, the sample is
comprised of patient records only from Central Florida and the records did not provide
information on race or ethnicity. However, health records used were from six sleep centers
located in five different cities. Furthermore, patient characteristics with respect to obesity (69%)
and hypertension (56%) in the study sample are consistent with those reported in the literature
(Devulapally et al., 2009; Somers et al., 2008; Wolk et al., 2003). Also, the percentage of OSA
(70%) in the total sample is similar to percentages reported in the epidemiologic literature
(Sassani et al., 2004). This argues for the generalizability of study findings.
Last, the high predictive value found for two or more high-risk diagnoses (88%) and
obesity (83%) in predicting OSA in this study was based on an OSA prevalence of 70% of this
sample. In the more general adult population, the incidence of OSA is lower. For example, the
incidence of OSA in the adult population according to the Sleep in America 2005 Poll of the
National Sleep Foundation analysis was about 25%. Thus, it would be expected that the
predictive value would be lower in the more general adult population than what was observed in
this study. However, it may be important to consider that the incidence of OSA in a PHC setting
is higher than in the general population (N. C. Netzer et al., 2003).
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Implications for Practice
The use of either obesity or two or more high-risk diagnoses for identifying patients at
risk for OSA in a PHC setting may impact the number of patients sent for a polysomnogram and
thus diagnosed with OSA. The literature relates the overwhelming number of patients with
undiagnosed OSA to an inadequate screening in the PHC setting (S. A. Chung et al., 2002;
Dodson, 2008; P. Lavie, 2006; Merritt, 2004; Reuveni et al., 2004; Skjodt, 2008). The use of two
or more high-risk diagnoses may present a fast and simple option for PCPs not currently using
the available screening tools to identify the patients at risk for OSA.
These high-risk diagnoses (hypertension, diabetes mellitus type 2, arrhythmia, and
coronary artery disease) are common diagnoses seen on a daily basis in a PHC. Therefore, PCPs
may not spend extra time for OSA assessment because they are already assessing the patients for
the common diagnoses. Also, the medical information system can easily create an electronic alert
based on the high-risk diagnoses algorithm that would prompt PCPs to order a polysomnogram.
The proper screening of high-risk patients leading to diagnosis and treatment of OSA has
the potential to improve patients‟ outcomes not only with respect of their improved health
conditions, but also improving their quality of life (Somers et al., 2008). Another aspect related
to proper OSA treatment is the benefit of health care savings. Besides the significant direct
health care costs associated with untreated OSA and the aggravation of many diseases, other
costs include motor vehicle accidents and lost productivity (Gurubhagavatula et al., 2008;
Sassani, 2004; Talmage et al., 2008). Work productivity has been estimated to be decreased in
37% due to sluggish thought process and neurocognitive impairment of untreated employees
with OSA (AlGhanim et al., 2008; Gurubhagavatula et al., 2008). Screening high-risk
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employees, diagnosing, and treating them with CPAP has shown significant economic benefit
(AlGhanim et al., 2008).
PCPs are in a key position to recognize patients at risk for OSA. However, several studies
have demonstrated that PCPs recognize less than 15% of patients identified with OSA (N. C.
Netzer et al., 1999; Reuveni et al., 2004; Skjodt, 2008). The use of obesity and two or more highrisk diagnoses may have a modest sensitivity of 69% and 44% respectively in identifying the true
positives for OSA, but it represents a significant advance in the identification of OSA high-risk
patients compared with the present screenings (less than 15%). The specificity of 68% for
obesity and 86% for two or more high-risk diagnoses in this population is significant in
identifying the true negatives for OSA.
The sensitivity and specificity of obesity and two or more high-risk diagnoses compared
to other screening tools are close enough to demonstrate their value as predictors for a positive
OSA diagnosis as seen in Table 6. Two or more high-risk diagnoses has a modest 44%
sensitivity, but considering the simple and easy way to use it in a PHC setting it may represent
more patients screened than the highest 84% sensitivity of the STOP-BANG. The sensitivity
detects the percentage of positive OSA identified by the predictor. However, the predictor is only
as good as much as it is used. For instance, the current percentage of PCPs using any screening
tool to identify the high-risk patients for OSA is about 15% (N. C. Netzer et al., 1999; Reuveni et
al., 2004; Skjodt, 2008). That means if the STOP-BANG is used only 15%, its sensitivity means
about 13% of patients screened whereas the simple two or more high-risk diagnoses has the
potential of identifying about 44% and obesity 69% of the patients in a PHC setting. When
comparing specificities, the two or more high-risk diagnoses has a better performance than most
of the screening tools with an 86% versus 56% of the STOP-BANG. Because of the high cost of
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a polysomnogram, it is important to have a predictor with a high specificity, which means a high
proportion of true negatives identified by the predictor. Therefore, by correctly identifying the
true negatives, the costs of unnecessary polysomnograms are avoided.

Table 6: Sensitivity and Specificity Comparison for OSA Positive (AHI/RDI ≥ 5)
Sensitivity
69%
44%
66%
54% to 86%
84%

Obesity
Two or more high-risk diagnoses
Epworth Sleepiness Scale
Berlin Questionnaire
STOP-BANG

Specificity
68%
86%
48%
43% to 87%
56%

Moreover, a cost analysis comparing the cost of false positives resulting in unnecessary
polysomnograms against the cost of undiagnosed OSA can be used to justify the use of obesity
or two or more high risk diagnoses as a means for screening to detect individuals who should be
referred for a polysomnogram. There are significant direct health care costs associated with
untreated OSA related to the aggravation of chronic diseases such as hypertension, diabetes
mellitus type 2, and dyslipidemia (Calvin & Somers, 2009; Cuhadaroğlu et al., 2009;
Devulapally et al., 2009; Khayat et al., 2009). Also demonstrated in the literature is the cost of
productivity loss due to sluggish thought process and neurocognitive impairment of untreated
employees with OSA, which has been estimated to be about 37% (AlGhanim et al., 2008;
Gurubhagavatula et al., 2008).
For the purpose of illustration, a cost analysis taking into consideration the cost of
decreased work productivity can be used to illustrate that even when true cost of false negatives

43

are underestimated, the cost of false positives more than justify using obesity and two or more
high-risk diagnoses to screen for OSA risk.
Suppose 100 patients are screened for OSA using obesity as a predictor, which has a false
positive rate of 32%, and another 100 patients are screened using two or more high-risk
diagnoses, which has a false positive rate of 14%. Estimating a yearly income of $40,000, a
decreased productivity of 37% is equivalent to a loss of $14,800 for each patient. Considering
that 70% of the 200 patients screened were positive for OSA, the annual productivity lost equals
to $2,072,000. The average polysomnogram costs about $800 (Gurubhagavatula, 2008). Out of
the 100 patients screened with obesity as a predictor, the cost of false positives would be
$25,600. For the other 100 patients screened with two or more high-risk diagnoses the false
positive cost would be $11,200. It is easy to visualize that the cost of false positive is
insignificant before the potential of cost of not diagnosing the positive patients for OSA.

Recommendations
The results of this study were significant to warrant further investigation to establish how
well these findings replicate in other primary health care practice populations. Replication in
other populations would support PCPs‟ wide use of these high-risk diagnoses and obesity to
identify patients at risk for OSA. For instance, a prospective study for one year using samples
from ten to twenty PHC practices in different states of the United States may be used to validate
these findings. Future research should identify patients‟ race and ethnicity to support replication
of findings in other populations. Additional analysis of these or future study data should be
conducted to explore which combination of high-risk diagnoses would be more likely to predict a
positive diagnosis of OSA. These results would provide a better understanding on how the use of
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high-risk diagnoses and obesity would improve the screening of OSA in a PHC setting. Finally,
research is needed regarding implementation of a screen based on obesity and/or two or more
high risk diagnoses. Study sites for this research should include a mix of (a) electronic health
records with a computerized alert triggered for the two or more high-risk diagnoses and for
obesity, and (b) traditional paper charts where the identification of these risk factors would rely
only on the healthcare provider‟s initiative.
There is a gap in the literature regarding high-risk diagnoses commonly seen in a PHC
setting as predictors for OSA high-risk. Findings from the present study should be disseminated
in several forms, such as professional publications, presentations at professional conventions and
local seminars. The findings from this study should be communicated with the primary care
practice community as well as the sleep medicine specialties.

Conclusion
The need to find alternative ways for proper screening of OSA high-risk patients is
evident from the continuous under-diagnosing of OSA. PCPs are positioned in a key place to
improve the number of patients diagnosed and treated for OSA as they treat patients for common
high-risk diagnoses (hypertension, diabetes mellitus type 2, dyslipidemia, arrhythmia, and
coronary artery disease) on a daily basis. The use of high-risk diagnoses to identify the patients
at risk for OSA in a PHC has the potential to improve OSA screening and diagnosis because it
may be a simple and fast way for PCPs to identify these patients. In this study, the interaction
term was not significant, indicating that the combination of obesity with two or more high-risk
diagnoses does not improve prediction of patients with OSA. However, either obesity or two or
more high-risk diagnoses were significant in the logistic regression analysis in predicting patients
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at risk for OSA. The odds ratios without the interaction term in the analysis indicated over fourfold likelihood for OSA in patients with obesity or two or more high-risk diagnoses. There was
no decrease in overall classification rate when the interaction term was dropped. The high
predictive value found for two or more high-risk diagnoses (88%) in predicting OSA in this
study, even considering some decrease due to lower incidence of OSA in a general adult
population, may be important to encourage PCPs to order a polysomnogram for these patients.
PCPs may have a reasonable degree of certainty when sending a patient for a polysomnogram
knowing that the predictive value of using two or more high-risk diagnoses is significant for a
positive OSA diagnoses. The ultimate goal of proper screening of high-risk patients leading to
diagnosis and treatment of OSA is to improve patients‟ health conditions and their quality of life.
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APPENDIX A: EPWORTH SLEEPINESS SCALE
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How likely are you to doze off or fall asleep in the situations described below, in contrast to
feeling just tired? This refers to your usual way of life in recent times. Even if you have not done
some of these things recently try to work out how they would have affected you.

Use the following scale to choose the most appropriate number for each situation:

0 = Would never doze
1 = Slight chance of dozing
2 = Moderate chance of dozing
3 = High chance of dozing

Situation Chance of dozing
1. Sitting and reading . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2. Watching TV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3. Sitting, inactive in a public place (e.g. a theatre or a meeting) . . . . . . .
4. As a passenger in a car for an hour without a break . . . . . . . . . . . . . . .
5. Lying down to rest in the afternoon when circumstances permit . . . . .
6. Sitting and talking to someone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7. Sitting quietly after a lunch without alcohol . . . . . . . . . . . . . . . . . . . . . .
8. In a car, while stopped for a few minutes in the traffic . . . . . . . . . . . . .

Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
A total score above 10 is abnormal, indicating high risk for OSA.
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APPENDIX B: BERLIN QUESTIONNAIRE
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Sleep Apnea
Height (m) ___________Weight (kg) _____________Age _____________Male / Female
Please choose the correct response to each question.
Category 1
1. Do you snore?
□ a. Yes
□ b. No
□ c. Don‟t know
If you answered ‘Yes’:
2. You snoring is:
□ a. Slightly louder than breathing
□ b. As loud as talking
□ c. Louder than talking
□ d. Very loud – can be heard in other rooms
3. How often do you snore?
□ a. Almost every day
□ b. 3-4 times per week
□ c. 1-2 times per week
□ d. 1-2 times per month
□ e. Rarely or never
4. Has your snoring ever bothered other people?
□ a. Yes
□ b. No
□ c. Don‟t know
5. Has anyone noticed that you stop breathing during your sleep?
□ a. Almost every day
□ b. 3-4 times per week
□ c. 1-2 times per week
□ d. 1-2 times per month
□ e. Rarely or never
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Category 2
6. How often do you feel tired or fatigued after your sleep?
□ a. Almost every day
□ b. 3-4 times per week
□ c. 1-2 times per week
□ d. 1-2 times per month
□ e. Rarely or never
7. During your waking time, do you feel tired, fatigued or not up to par?
□ a. Almost every day
□ b. 3-4 times per week
□ c. 1-2 times per week
□ d. 1-2 times per month
□ e. Rarely or never
8. Have you ever nodded off or fallen asleep while driving a vehicle?
□ a. Yes
□ b. No
If you answered ‘Yes’:
9. How often does this occur?
□ a. Almost every day
□ b. 3-4 times per week
□ c. 1-2 times per week
□ d. 1-2 times per month
□ e. Rarely or never
Category 3
10. Do you have high blood pressure?
□ Yes
□ No
□ Don‟t know
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APPENDIX C: SCORING BERLIN QUESTIONNAIRE
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The questionnaire consists of 3 categories related to the risk of having sleep apnea. Patients can
be classified into High Risk or Low Risk based on their responses to the individual items and
their overall scores in the symptom categories.

Categories and Scoring:

Category 1: items 1, 2, 3, 4, and 5;
Item 1: if „Yes‟, assign 1 point
Item 2: if „c‟ or „d‟ is the response, assign 1 point
Item 3: if „a‟ or „b‟ is the response, assign 1 point
Item 4: if „a‟ is the response, assign 1 point
Item 5: if „a‟ or „b‟ is the response, assign 2 points

Add points. Category 1 is positive if the total score is 2 or more points.

Category 2: items 6, 7, 8 (item 9 should be noted separately).
Item 6: if „a‟ or „b‟ is the response, assign 1 point
Item 7: if „a‟ or „b‟ is the response, assign 1 point
Item 8: if „a‟ is the response, assign 1 point

Add points. Category 2 is positive if the total score is 2 or more points.
Category 3 is positive if the answer to item 10 is „Yes‟ or if the BMI of the patient is greater
than 30kg/m2.

(BMI is defined as weight (kg) divided by height (m) squared, i.e.., kg/m2).

High Risk: if there are 2 or more categories where the score is positive.

53

Low Risk: if there is only 1 or no categories where the score is positive.
Additional Question: item 9 should be noted separately.

54

APPENDIX D: STOP-BANG SCORING QUESTIONNAIRE
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1. Snoring: Do you snore loudly (louder than talking or loud enough to be heard through closed
doors)? Yes / No

2. Tired: Do you often feel tired, fatigued, or sleepy during daytime? Yes / No

3. Observed: Has anyone observed you stop breathing during your sleep? Yes / No

4. Blood pressure: Do you have or are you being treated for high blood pressure? Yes / No

5. BMI: BMI more than 35? Yes / No

6. Age: Age over 50 yr old? Yes / No

7. Neck circumference: Neck circumference greater than 40 cm (16 inches)? Yes / No

8. Gender: Gender male? Yes / No

High risk of OSA: Answering yes to three or more items

Low risk of OSA: Answering yes to less than three items
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APPENDIX E: SPSS FILE FOR DATA COLLECTION
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Patient's
Number

Age

Gender

BMI

HTN

DM

Legend:
BMI: Body Mass Index
HTN: Hypertension
DM: Diabetes Mellitus type 2
CAD: Coronary Artery Disease
AHI: Apnea-Hypopnea Index
RDI: Respiratory Disturbance Index
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Dyslipidemia Arrhythmia

CAD

AHI
/RDI
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